Stockreport

Beam Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare Disease Day

Beam Therapeutics Inc.  (BEAM) 
PDF CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base [Read more]